πŸ‡ΊπŸ‡Έ FDA
Patent

US 11193129

Modulatory polynucleotides

granted A61PA61P43/00

Quick answer

US patent 11193129 (Modulatory polynucleotides) held by VOYAGER THERAPEUTICS, INC. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P43/00